Gene expression profiling in multiple myeloma cells treated with the novel anti-myeloma agents zoledronate and fluvastatin.

被引：0
|
作者：
Molloy, TJ
Cindy, BB
Deng, YM
Spencer, A
Ma, DF
机构：
[1] Alfred Hosp, Myeloma Res Grp, Melbourne, Vic, Australia
[2] St Vincents Hosp, Sydney, NSW 2010, Australia
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5078
引用
收藏
页码：351B / 351B
页数：1
相关论文
共 50 条
  • [31] Angiogenic signature of multiple myeloma determined by gene expression profiling
    Hose, Dirk
    Moreaux, Jerome
    Meissner, Tobias
    Rossi, Jean-Francois
    Benner, Axel
    Mahtouk, Karene
    Seckinger, Anja
    Heiss, Christiane
    Hundemer, Michael
    Reme, Thierry
    Hillengass, Jens
    Herde, Katja
    Bertsch, Uta
    DeVos, John
    Wenisch, Sabine
    Pantesco, Veronique
    Jauch, Anna
    Jourdan, Eric
    Goldschmidt, Hartmut
    Klein, Bernard
    Moehler, Thomas
    BLOOD, 2007, 110 (11) : 732A - 733A
  • [32] Metascoring and Gene Expression Profiling in Clinical Routine in Multiple Myeloma
    Meissner, Tobias
    Seckinger, Anja
    Reme, Thierry
    Hielscher, Thomas
    Moehler, Thomas
    Neben, Kai
    Goldschmidt, Hartmut
    Klein, Bernard
    Hose, Dirk
    BLOOD, 2011, 118 (21) : 1684 - 1685
  • [33] Molecular dissection of hyperdiploid multiple myeloma by gene expression profiling
    Chng, Wee J.
    Kumar, Shaji
    VanWier, Scott
    Ahmann, Greg
    Price-Troska, Tammy
    Henderson, Kim
    Chung, Tae-Hoon
    Kim, Seungchan
    Mulligan, George
    Bryant, Barbara
    Carpten, John
    Gertz, Morie
    Rajkumar, S. Vincent
    Lacy, Martha
    Dispenzieri, Angela
    Kyle, Robert
    Greipp, Philip
    Bergsagel, P. Leif
    Fonseca, Rafael
    CANCER RESEARCH, 2007, 67 (07) : 2982 - 2989
  • [34] Daratumumab Directly Induces Human Multiple Myeloma Cell Death and Acts Synergistically with Conventional and Novel Anti-Myeloma Drugs
    Kong, Sun-Young
    Li, Xian-Feng
    Nahar, Sabikun
    Song, Weihua
    de Weers, Michel
    Parren, Paul W. H. I.
    Richardson, Paul
    Munshi, Nikhil C.
    Anderson, Kenneth C.
    Tai, Yu-Tzu
    BLOOD, 2010, 116 (21) : 1241 - 1242
  • [35] Gene expression profiles as prognostic factors in patients with multiple myeloma treated with conventional versus novel agents in correlation with outcome
    Broyl, Annemiek
    Hose, Dirk
    De Knegt, Yvonne
    Lokhorst, Henk
    Goldschmidt, Hartmut
    Van Duin, Mark
    Sonneveld, Pieter
    BLOOD, 2007, 110 (11) : 932A - 932A
  • [36] A new generation XIAP inhibitor induces apoptosis of human myeloma cells and synergises with conventional and novel anti-myeloma therapeutics
    Khong, Tiffany
    Spencer, Andrew
    BLOOD, 2007, 110 (11) : 270B - 270B
  • [37] Predicting Early Mortality in Multiple Myeloma Patients Treated with Novel Agents
    Geraldes, Catarina
    Roque, Adriana
    Sarmento-Ribeiro, Ana Bela
    Ribeiro, Maria Leticia
    Bergantim, Rui
    Trigo, Fernanda
    Chacim, Sergio
    Macedo, Ana
    Viveiros, Carolina
    Joao, Cristina
    Neves, Manuel
    Lucio, Paulo
    BLOOD, 2018, 132
  • [38] Molecular profiles of sensitivity or resistance of multiple myeloma (MM) cells to conventional and novel anti-myeloma agents: Clinical implications for rationale design of strategies to overcome drug-resistance in MM.
    Mitsiades, CS
    Mitsiades, N
    McMullan, CJ
    Poulaki, V
    Hideshima, T
    Chauhan, D
    Munshi, NC
    Joseph, M
    Libermann, TA
    Anderson, KC
    BLOOD, 2003, 102 (11) : 189A - 189A
  • [39] Proteomic Profiling of Multiple Myeloma: Correlation of Protein and Gene Expression Data
    Edmondson, Ricky D.
    Thyparambil, Sheeno P.
    MacLeod, Veronica
    Barlogie, Bart
    Shaughnessy, John D., Jr.
    BLOOD, 2008, 112 (11) : 601 - 602
  • [40] Toward the molecular classification of myeloma: Gene expression profiling in the diagnosis, prognosis, and treatment of multiple myeloma.
    Zhan, F
    Bumm, K
    Tian, E
    Xu, H
    Zangari, M
    Desikan, R
    Badros, A
    Morris, C
    Toor, A
    Anaissie, E
    Tricot, G
    Barlogie, B
    Shaughnessy, J
    LEUKEMIA, 2001, 15 (03) : 493 - 493
12345